Tilray Medical

Tilray Medical is a global pioneer in the research, cultivation, production, and distribution of medical cannabis. As a dedicated division of Tilray Brands, Inc., the company provides EU-GMP certified medical cannabis products, including whole flower, ground flower, and full-spectrum oral solutions, to patients, physicians, pharmacies, and hospitals across five continents. Tilray Medical is actively involved in advancing cannabinoid science, partnering with leading academic and clinical institutions worldwide to study the efficacy of cannabinoids in treating conditions such as glioblastoma, pediatric epilepsy, anxiety, and chemotherapy-induced nausea. Through strategic acquisitions like Lyphe Group and HelloMD, the company is building a vertically integrated, patient-centric medical ecosystem that combines clinical care, digital pharmacy services, and pharmaceutical distribution.